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Abstract 
Purpose: To explore and describe lymphoma survivors’ thoughts and perceptions of 
the components of a nurse-led lymphoma survivorship clinic intervention.  
Methods: An exploratory, qualitative descriptive study using interviews from 10 
participants who had transitioned post-treatment into the survivorship phase via a 
nurse-led lymphoma survivorship clinic intervention. 
Results: Thematic analysis revealed three major themes: Reassurance and 
individualised care; Information and support; and Empowerment. Participants 
described the reassurance they gained from having contact with a health professional 
post-treatment who individualised information and support. A survivorship care plan 
and treatment summary was developed for this study and was believed to be very 
patient-centred and helpful. This enabled participants to take back control of their 
health and well-being and to rebuild confidence.  
Conclusions: In this study, participants expressed a need for patient-centred follow-up 
care that addressed their concerns and supported them in the survivorship phase to 
get their life back on track. Nurse-led follow-up may offer a viable model of post-
treatment survivorship care to lymphoma cancer survivors.   
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Introduction 
Lymphomas are haematological cancers that originate from the lymphatic 
system, and are mainly categorised as either Hodgkin (HL) or non-Hodgkin lymphoma 
(NHL) (American Cancer Society, 2014). Worldwide, lymphomas represent the sixth 
most commonly diagnosed cancer (Surveillance Epidemiology and End Results 
(SEER), 2014). Australian incidence is increasing with an estimated 6,323 cases 
expected in 2017, which will equate to 4.6% of all cancer cases (Cancer Australia, 
2017). However, developments in treatment and supportive care options such as 
chemotherapy, haematopoietic stem cell transplantation, radiotherapy and targeted 
therapies have improved five year survival to 76% (Cancer Australia, 2017). With 
increased remission and survival rates, many survivors experience issues and 
concerns, called unmet needs, which can impact quality of life and well-being (Carey 
et al., 2012; Sant et al., 2014). These can relate to issues such as: fatigue; poor 
nutrition; exercise capacity; cognition impairment; fear of recurrence; fertility, 
relationships; finances; employment; and insurance (Taylor et al., 2015; van der Poel 
et al., 2014). Health can be further compromised by late effects of treatment such as 
cardiovascular disease and second cancers (Grinyer, 2010; Ng et al., 2011; Travis et 
al., 2012), often experienced earlier than the general population (Panek-Hudson, 
2013).  
Haematological survivorship studies mainly report on mixed haematological 
samples regardless of variations in clinical features, treatment, curability and relative 
survival (Hall, Campbell, et al., 2013; Lobb et al., 2009; McGrath, 2014). A study of 
lymphoma (n=236) and myeloma (n=178) survivors on anxiety, depression and unmet 
needs in the early survivorship period (under two years) reported decreasing anxiety 
and depression rates in the myeloma cohort and increasing rates in the lymphoma 
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cohort (Oberoi et al., 2017). The authors indicated a need for cohort specific studies, 
especially in the early survivorship period (Oberoi et al., 2017) to ensure targeted 
support. Lymphoma only studies often reflect a survivorship period beyond two years 
at assessment (Ferrer, Huedo-Medina, Johnson, Ryan, & Pescatello, 2011; Friedman 
et al., 2010; Oerlemans et al., 2014), which may not reflect the unique needs of those 
who have recently completed treatment, limiting generalisability. A recent study by the 
authors (Monterosso et al., 2017) reported on focus groups with lymphoma survivors 
(n=17), the majority (n=13, 76%) who were 12-30 months post-treatment completion. 
Participants recounted unmet needs related to information, coping strategies and 
support, especially when transitioning into survivorship. Findings suggested cancer 
nurse coordinators could be a feasible approach to delivering structured, 
individualised support early post-treatment (Monterosso et al., 2017).  
Nurse-led models of survivorship care have been proposed to transition 
patients post-treatment and have demonstrated acceptable outcomes in haematology 
cohorts (Gates et al., 2015; Howell et al., 2012; John & Armes, 2013). As a minimum, 
nurse-led models should include: administration of survivor-specific needs 
assessments to identify patient concerns (McDowell et al., 2010; Stricker et al., 2011); 
development and delivery of a survivorship care plan and treatment summary 
(SCPTS), to guide holistic follow-up (Clinical Oncology Society of Australia, 2016; 
MacMillan Cancer Support & NHS Improvement, 2010; McCabe, Bhatia, et al., 2013); 
and support to assist survivors to take ownership of their health and well-being 
(Bodenheimer et al., 2002; Kuijpers et al., 2013). To date, studies that have tested 
nurse-led models of care have focused on survivors of common cancers (breast, 
prostate, colon) (Jefford et al., 2016; Maly et al., 2017; Taylor et al., 2015), been based 
in acute care settings, used long consultations, and involved more frequent patient 
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contact (Cooper et al., 2010; De Leeuw & Larsson, 2013), which may preclude 
generalisability to other cancers or limit economic viability.  
In order to provide lymphoma survivors with specific and responsive supportive 
care, the unique issues and unmet concerns of this cohort need to be assessed in the 
early survivorship period (under one year). The aim of this sub-study was to provide 
qualitative semi-structured interview data from a sample of participants who had been 
randomised to the intervention group of the Care After Lymphoma (CALy) phase II 
randomised controlled trial study (RCT) (Taylor et al., 2016). The RCT aimed to 
develop and test a nurse-led lymphoma survivorship clinic (NLSC) intervention to 
assist participants transitioning from treatment completion into the early survivorship 
phase. This study will add to the limited literature that exists in lymphoma specific early 
survivorship. 
 
Methods 
Methodological framework 
A qualitative descriptive methodology was utilised to provide a comprehensive 
summary of a specific experience by the participants (Neergaard, Olesen, Andersen, 
& Sondergaard, 2009; Sandelowski, 2000), using a semi-structured interview design. 
The interview schedule consisted of the same open-ended questions and was 
developed by the researchers. To ensure participants felt able to express themselves 
and their perceptions freely, interviews were conducted by an experienced 
independent researcher.  
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Sample and setting  
A purposive sample of lymphoma patients from a large tertiary hospital cancer 
centre in Perth, Western Australia were recruited from the intervention group of the 
RCT. A non-probability purposive sampling provides rich information from participants 
who have the greatest amount of in-depth knowledge and experience of a particular 
circumstance or event (Patton, 2014). Only participants who had completed all 
aspects of the NLSC intervention were approached by the survivorship cancer nurse 
conducting the clinic intervention. These participants had completed four measures: 
Short Form Survivor Unmet Needs Survey (SF-SUNS); Depression Anxiety Stress 
Scale (DASS21); Mini Mental Adjustment to Cancer Scale (Mini-MAC); and Patient 
Empowerment Scale at three time points; baseline (prior to randomisation), 3 months 
and 6 months. At the first NLSC appointment (approximately one week after baseline), 
participants completed and received an individualised lymphoma SCPTS, developed 
for this study (Taylor et al., 2016). Participants’ GP were sent a copy. A motivational 
interview technique was used to provide evidenced-based information, advice and 
support at the first intervention appointment and reinforced with additional resources 
and support as required over the next two appointments.  
All participants approached agreed to be interviewed. Each participant was nine 
months’ post-treatment completion and the sample reflected an equal gender 
distribution and range of ages. Data saturation was achieved after ten interviews.  
 
Interviews 
The study was approved by the relevant hospital and university human 
research ethics committees. Informed written consent was obtained by all participants 
prior to interview scheduling. Interviews were conducted from February 2016 to May 
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2017 and occurred after the last NLSC appointment. Telephone interviews were 
conducted at a time convenient for the participant and were digitally recorded. The 
following are examples of the interview questions: ‘Did you have any concerns or 
needs not addressed by any of the questions?’; ‘What aspects of the clinic would you 
want to stay the same for future patients?’; ‘Would you recommend the clinic to other 
patients finishing treatment?’; ‘How do you feel about having the health concerns, 
goals and actions individualised to yourself?’; and ‘Overall how useful was the SCPTS 
to you?’ Interviews were transcribed verbatim, de-identified and an identifier code 
applied. Digital recordings and transcribed interviews were saved in a password-
protected file on a secure server. After the first three interviews, the question order 
was slightly altered to enhance the flow of the interview. 
 
Data Analysis 
Interview transcripts were imported into NVivo 11 (NVivo 11, 2016) to facilitate 
management of data and completion of the analysis. Thematic analysis was used to 
establish patterns and themes within the text (Grbich, 1998; Patton, 2014; Smith, 
2007). Thematic analysis allows for participant diversity of ideas and perceptions 
(Smith, 2007), thus providing a depth of information regarding the personal impact of 
the NLSC on the participant. Subthemes were developed from the data, and allowed 
for a logical organisation of the themes that emerged. The criteria of credibility, 
auditability and fittingness were applied to the data analysis process to ensure rigor 
(Beck, 1993). Credibility was maintained by triangulation with another member of the 
research team (Beck, 1993) to ensure independent reading and analysis of the 
transcripts by KT and CB who allocated codes and themes to the generated data 
(Braun & Clarke, 2006). The researchers met to discuss the codes and any 
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discrepancies before consensus on emerging themes was reached. The ample use of 
extracts or quotes from the data demonstrated fittingness to the agreed codes. A 
comprehensible audit trail maintained auditability, demonstrated by documentation of 
research planning through to analysis, and through a reflective discourse and debrief 
process with colleagues.  
 
Results 
Participants 
Ten semi-structured interviews were conducted with all participants willing to 
share an opinion for each of the interview guideline areas. Demographic and disease 
information is shown in Table 6.3.1. There were equal numbers of males and females, 
with similar age range (24 – 74 years) and lymphoma type. The majority of participants 
resided within the metropolitan area (n=8, 80%), were working (n=6, 60%), were 
married or defacto (n=6, 60%) and had a university degree or trade qualification (n=8, 
80%).  
Time elapsed from end of study to interview ranged from 1 to 26 days (mean 
6.5 days, SD 7.8 days). The majority of interviews (n=8) were done within 5 days. No 
time limit was set and interviews ranged from 17 minutes through to 48 minutes (mean 
30.5 minutes).  
Table 1 Demographic Characteristics for Interview Participants (n=10) 
Characteristics Males 
n=5 
(50%) 
Females 
n=5 (50%) 
Age group at baseline 
  24-25 
  48 
  65-74 
 
  2  
  1  
  2  
 
  2  
  1  
  2  
Lymphoma diagnosis 
  Non-Hodgkin 
 
  2  
  
  2  
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  Hodgkin   3    3  
Highest level of education 
  Secondary school or less 
  Trade / vocational college 
  University 
   
  1  
  2  
  2  
   
  1  
  2 
  2 
Employment status 
  Working 
  Retired 
  No return to work date 
   
  4 
  1 
  - 
   
  2 
  2 
  1  
Marital status 
  Single 
  Married / defacto 
  Divorced 
  
  1 
  4 
  - 
   
  2 
  2 
  1  
Residence 
  Metropolitan 
  Regional 
  
  4  
  1  
  
  4 
  1 
 
Themes 
Three major themes emerged from analysis and coding of data: Reassurance 
and individualised care; Information and support; and Empowerment. Subthemes 
have been included to add clarity. 
 
Reassurance and individualised care 
Overall, the NLSC was well received and deemed a positive experience for 
participants, although it would have been reassuring to know about the clinic 
intervention during treatment. The assessment questionnaires and the SCPTS were 
perceived to facilitate individualised care.  
 
Timing of support 
Most participants indicated they would have liked knowledge of the clinic 
intervention during treatment so they could feel reassured that someone was still 
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interested in supporting them and they were ‘not going to be abandoned’. This would 
take the form of a contact person they could trust.  
 “Just knowing that I was still going to get some support” F_25yo_HL 
 
“But to know that look, don’t worry, after treatment you are going to see a nurse, 
that would have been very calming for me” F_64yo_HL 
 
The use of questionnaires to elicit unmet needs and concerns 
Questionnaires were used to elicit unmet needs and areas of concern that could 
be discussed with participants at the NLSC appointment. Participant responses served 
as a focus for the follow up appointment. Feedback about the questionnaires indicated 
some questions were hard to answer. 
 
“Sometimes I found that I couldn’t say yes or no to the questions, because they 
didn’t apply I suppose, and I had to answer” F_64yo_HL 
 
Nonetheless, the questionnaires were able to cover aspects thought to be 
important to participants’ overall wellbeing, as one said,  
   
“They covered a multitude of the different things like your emotional well-being, 
mental well-being and physical well-being, all the things that you know you can 
struggle with” F_24yo_HL 
 
The supportiveness of the intervention  
All participants wanted the intervention structure to remain the same, describing 
the one-to-one, personalised nature of the intervention a valuable opportunity to talk 
to someone who was not family, friends or a doctor. They described being listened to 
and ‘feeling safe’ to ask questions on a range of topics, especially questions they felt 
they could not ask their haematologist. Participants indicated support was 
individualised and felt reassured they could get their life back on track.  
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“The one-on-one was really helpful because then you felt like you could pretty 
much ask anything, or talk about anything, and you didn’t feel like there would be 
other people around to listen to your private conversations. A safe space, ask 
questions and get reassurance and the right answers. That was good” F_24yo_HL 
 
“Someone that you can speak to and address the problems that you don’t get the 
time with the doctors to talk about” F_64yo_HL 
 
Another participant also commented on how he could discuss other aspects of the 
cancer experience. He said, 
 
“What I particularly liked was the opportunity to have a conversation around things 
other than treatment. Dealing with some of the fears that you may have that you 
didn’t feel like you could ask your specialist about. Or where do I go for 
complementary therapies. The kind of questions that specialists I don’t think are 
necessarily geared for. Or don’t have time really to cover. The ability to have a 
chat to a nurse that can help you through the next part of the journey” 
M_48yo_NHL 
 
A couple of participants indicated that the intervention should have been 
conducted according to patient preferences. This included a preference for the NLSC 
to be away from the hospital and closer to their home.  
 
“We should be providing services close to home where possible and I think there 
are some really great opportunities for the survivorship study to get out into the 
community even though they are still run by the hospital” M_48yo_NHL 
 
Although two participants found returning to the hospital traumatic, they felt the 
NLSC experience helped them to overcome their aversion as it was felt to be a safe 
place they could communicate their fears and receive reassurance. 
 
“The torture as a result of the treatment – going back to the hospital made me feel 
all that. It actually helped me deal with the fact that I can go to the hospital and not 
feel sick – so there was a positive to” M_48yo_NHL 
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Nurse contact and rapport 
It was also felt contact should have been more frequent with telephone support 
between face to face visits, to provide extra support and to ‘check-in’ with the 
participant.  
 
“I think you need to make them a bit closer together – a bit more frequent. And 
also make it where patients can choose. Make it more patient-driven - where the 
patient tells you how often they want to see or talk to someone” F_48yo_NHL 
 
There was also an indication that many wanted the contact to go beyond the study 
timeframe. As one participant said, 
 
“I don’t feel like I am on my own steam yet. I am thinking 2 years before I have got 
my confidence and hopefully my health back” F_64yo_HL 
 
All participants described the relationship with the nurse who ran the intervention 
as comfortable and flexible, and felt they could call or speak to her with any issues if 
they wanted to. Participants provided comment and perceptions of the nurse as 
follows:  
 
“And she did explain things so that I understood them more. She was really good 
at making you feel relaxed” F_48yo_NHL 
 
“You felt like you had enough time to talk about and ask questions you didn’t feel 
rushed and I think that was really good” F_24yo_HL 
 
 
Survivorship care plan and treatment summary 
The written patient-centred SCPTS was described as reassuring when it guided 
follow-up and for keeping on track with healthy lifestyle behaviours.  
 
“Yes, it was good because it is reassuring, it is a guideline of what to do which I 
needed and knowing what to look out for and should be doing” F_64yo_HL 
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Feedback from participants regarding the SCPTS being sent to the GP indicated 
only two GPs discussed the SCPTS with them. Other participants indicated they either 
had not seen the GP or the GP acknowledged receipt but did not discuss.  
 
Information and support 
Participants appreciated the opportunity to discuss, record and receive written 
individualised information, support and resources. Although some information such as 
late effects was confronting at the time, it was nevertheless appreciated. All felt the 
information received at the NLSC was relevant and appropriate because it was tailored 
to their unique needs. Most felt they had not received this information or support from 
the treating team, however, it was acknowledged that possibly verbal information had 
been given but not retained.  
 
Individualisation of the SCPTS 
Participants liked the individualisation of the health concerns, goals and actions, 
and the accompanying written information and/or contacts.  
“When I did have a concern, I was given printed notes about those issues and I 
think that is really good. Because I do have trouble with my memory now, and I 
can go back over those notes and sometimes it is like reading it anew, you know” 
F_64yo_HL 
 
The treatment summary was well-received with most participants describing it as 
‘good to have’, especially as a tool for communication with other health professionals.  
 
“I think it was useful to sit down and have that initial meeting. I think it was really 
good that it was sent to my GP” F_25yo_HL 
 
However, one participant was unsure of the value to himself,  
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“But I think this kind of treatment summary is the sort of thing I would give to my 
GP, or if I am seeing a new Dr, or if I was travelling and I got sick. I almost feel like 
it’s less useful for me, but more useful for other people” M_24yo_HL 
 
One participant felt the terminology related to the disease location could have 
been put in simpler language and this helpful recommendation was utilised for 
subsequent treatment summaries.  
 
“Sometimes you don’t always understand the medical terms so I think putting it 
into more simpler language would be a bit more helpful” F_48yo_NHL 
 
Late effect information 
The potential late effect information given on the SCPTS was individualised to 
each participant. It came as a shock to many that heart disease and other cancers, for 
example, were possible consequences of the treatment received.  
 
“Well that was a bit of a shock to me because they hadn’t been mentioned prior to 
the treatment. … but at the same time, it was probably easier on me not knowing 
anyway” F_64yo_HL 
 
Participants appreciated having the information and felt it could help with GP 
consultations, specifically around planning of health management into the future. 
 
“That gave me something to go to my GP with and go okay I think I need to monitor 
this and this. And it helped me set out a care plan with my Dr as well” F_48yo_NHL 
 
“It is always a bit overwhelming, but I think it is a good way to highlight the possible 
things that could happen. I think it reduces you’re stress because you are not just 
in the dark about it. I think it is really important for yourself and the GP. If anything 
does change you know at least you are going to get it early” F_24yo_HL 
 
One participant indicated they had heard the potential late effect information at 
diagnosis and another described being told there were some possible late effects after 
she had completed treatment,  
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“Oh, he just briefly spoke about ‘you just need to be careful, you need to look after 
your skin, you need to do annual breast checks, you need to look after your heart. 
You know there is a possible risk you could get these problems in the future’. That 
is sort of how he mentioned it” F_24yo_HL 
 
Neither participant had received written information and did not feel they knew 
how to follow-up these risk factors. This was an important consideration when 
developing the SCPTS to ensure follow-up suggestions for the GP and participant 
were given. 
 
“[GP] just asked me to come in and discussed it with me and then he kind of just 
saved it and then he linked me in with support services to make sure I was 
monitoring all of my side-effects, so I think he thought it was good” F_25yo_HL 
 
 
Empowerment 
Most participants perceived the intent of the NLSC was to assist with 
transitioning away from a reliance on the treating team, to taking responsibility for 
monitoring and seeking support.   
Nurturing empowerment 
All participants described the SCPTS as useful and perceived it as a means to 
remind them to ‘stay on track’ with healthy lifestyle behaviours or for encouragement 
with achieving their goals.   
 
“It just kind of helped remind me of my goals, and every time I had the meeting 
with [KT], it was like a kind of thing to remember my goals and I thought was a 
really beneficial thing” M_24yo_HL 
 
Although one participant described the initial discussion and plan as helpful, she 
felt she should not have had to seek out services and arrange appointments.  
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“Maybe actually getting linked into the services they talk about. Rather than just 
getting the information and being left with it, it was kind of like I had to go and seek 
it out myself. I think it would have been really helpful to have someone contact 
me” F_25yo_HL 
 
It appeared she did not want to take responsibility for her follow-up care. The 
remaining participants described understanding and appreciating the need to take 
back control of their health and well-being. They described the opportunity to discuss 
and write down their own health concerns, health goals and the actions they planned 
to take with a health professional as confidence building and assisted in increasing 
their positivity post-treatment completion.  
“There are definitely days where you go thru and you start to question yourself, 
but being able to talk to someone about it made me feel more confident about 
being finished” M_25yo_HL 
 
“I started thinking a bit more positive” M_71yo_HL 
 
Participants noted that having the opportunity to record and discuss participant-
specific issues had personalised both the appointment and the SCPTS.   
 
“It identified what you personally were worried about and it wasn’t just a general 
thing that everyone can be worried about, but it was specific to you. And then 
having the specific needs addressed with a certain plan or the actions column that 
you could put in place. I think that was really helpful because you see how you 
could be proactive about things” F_24yo_HL 
 
Monitoring progress 
Participants felt the follow-up over the next six months in the NLSC allowed them 
to monitor their progress and see how they were going. 
 
“That was good. It was something to monitor my progress and it feels more 
personal” M_25yo_HL 
 
“It sort of crystallises your thinking for the future. If you don’t do something like that 
you tend to drift along day to day” F_74yo_NHL 
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Receiving written and contact information for support allowed participants to 
engage and take ownership for how and when they dealt with their goals and 
concerns. Even when issues remained unmet, having the issue normalised was 
equally important. 
 
“Well the fatigue and the memory [problems] I have still got. It was useful to find 
that other people suffer the same things, that I am not alone on that!” F_64yo_HL 
 
Usefulness of general health information 
Participants received general health and screening information and felt it was 
helpful. Most read it again at home, then put it aside. They felt the value was in having 
it to refer to if needed.  
 
“I think that it is really good to get the information and just have it there. I thought 
that was very handy” F_24yo_HL 
 
This document was not sent to the GP, as GPs involved in evaluating the SCPTS 
for content clarity, internal consistency and content validity, indicated they knew this 
information and did not want it. It was noteworthy that two participants had given it to 
the GP and it had guided follow-up care. 
 
“I basically took all the information into my GP and let him read thru it and he used 
it to help guide my care plan in the right direction” F_48yo_NHL 
 
Discussion 
This study contributes to the growing body of cancer-specific survivorship 
literature. The current model of specialist follow-up care for cancer survivors is 
inadequate, with many survivors experiencing unmet needs that can remain poorly 
addressed throughout the survivorship continuum (De Leeuw & Larsson, 2013). It is 
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essential survivorship care incorporates an awareness of treatment and disease, long-
term and late effect risks, as well as healthy lifestyle behaviours (Taylor et al., 2015), 
and facilitates communication amongst all health professionals and the patient and 
family. Expertise in the provision of health promotion, support and information has 
always been the purview of cancer nurses (Jackson et al., 2013), therefore nurse-led 
models should be considered within any proposed model of survivorship care.   
This study involved a cohort of lymphoma participants and specifically targeted 
those in the early survivorship phase (first nine months’ post-treatment). Studies that 
involve a single subtype of haematological cancer are important in ascertaining the 
psychosocial and supportive care interventions that are specific and most appropriate 
(Oberoi et al., 2017). Assessing and providing an intervention in the early survivorship 
period has been shown to lead to a reduction in the unmet needs as survivors continue 
beyond five years (McDowell et al., 2010). 
Participants described having time within the NLSC appointment to ask 
questions and seek individualised support as fundamentally helpful. An important point 
of difference with medical follow-up where participants perceived the specialist as too 
busy, or perhaps not interested when they were seeking reassurance and support. 
Interestingly, some participants would have preferred a follow-up appointment away 
from the hospital, an important consideration with future planning of nurse-led clinics. 
Participants had not previously met the nurse who provided the intervention, she is 
however, a cancer nurse coordinator with extensive haematology/oncology nursing 
and counselling experience and qualifications. A health professional who can quickly 
build a strong and positive rapport allows participants a greater opportunity to explore 
their own unmet needs (Ross, 2013). This may be why participants responded 
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favourably to the intervention and is important when considering nurse-led models of 
survivorship care. 
Empowering participants with an individualised SCPTS that provided disease 
and treatment knowledge, and allowed them to assume responsibility for their future 
health and well-being (Taylor & Monterosso, 2015), was described as helpful from all 
participants. The expectation of younger survivors living longer with potential issues is 
important (Jabson & Bowen, 2013), nevertheless all participants in this study, 
regardless of age, appreciated the follow-up guidance they could discuss and 
implement with their GP. Information on general health and screening allowed 
participants a sense of independence of when and how they would seek follow-up. Of 
particular importance to participants was the opportunity to personalise the SCPTS 
and concentrate on what was important to them as they moved forward after treatment 
had completed. Conversely, our study revealed a small subset of participants who 
were not ready to take back control of their future health and well-being. It is important 
to acknowledge those patients and provide individualised support that meets their 
needs at the time, without building further dependency in the survivorship phase. 
Survivorship literature highlights the concept of ‘teachable moments’ (Alfano et 
al., 2012; Grant & Economou, 2008; Hewitt et al., 2005; Panek-Hudson, 2013) at the 
end of active treatment to support and promote patient participation in healthy lifestyle 
behaviours. It was thought that participants in this study would need to be encouraged 
to engage in healthy lifestyle behaviours. However, it was evident that participants did 
feel a need to improve their health, and for some, change their lifestyle to adopt 
healthier lifestyle behaviours they had not been able to do during the stress of 
treatment. These participants particularly described the opportunity to revisit the 
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SCPTS over the preceding months allowed them to monitor and reflect on their 
achievements and help them to keep focused on their goals. 
 
Limitations 
This study reflects the views of a subset of lymphoma participants who 
underwent a nurse-led clinic survivorship intervention and therefore could not be 
generalisable to the wider survivorship population who have experienced a nurse-led 
clinic. Nonetheless, the use of qualitative interview research allowed an opportunity to 
gain a deeper understanding of the experiences of this select group. The findings are 
presented to help build research that is based on patient experience and feedback. 
The small number of participants is not a methodological limitation in qualitative 
research when data saturation is reached.  
 
Conclusion  
The interviews were conducted to ascertain the participant’s perception of the 
efficacy and value of the components of the nurse-led intervention and to highlight any 
issues or challenges for this cohort that could be better addressed in the future. 
Survivorship care offered by nurses may address the patient-perceived unmet needs 
at the conclusion of active treatment. Participants indicated the need for security in 
knowing there would be support when treatment completed and would likewise value 
the opportunity to have their concerns heard. An individualised SCPTS that empowers 
survivors to address healthy lifestyle issues and provide a follow-up guide for late 
effects of the disease and treatment assists in refocusing responsibility back to the 
patient. Nurse-led survivorship care may offer an acceptable model to deliver patient-
 20 
centred post-treatment follow-up. This model allows the time required to individualise 
and tailor supportive survivorship care. 
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